The Board of Directors of Aster DM Healthcare is scheduled to meet on November 06, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. The board will also consider the adoption of the Aster DM Healthcare Limited Employee Stock Option Scheme – 2025 (“ESOS 2025”).
Board Meeting Scheduled
A meeting of the Board of Directors of Aster DM Healthcare Limited will be held on November 06, 2025. The board will review key strategic and compliance matters.
Financial Results on the Agenda
The primary focus of the meeting will be the review and approval of the unaudited standalone and consolidated financial results for Q2 FY26, specifically the quarter and half year ending on September 30, 2025.
Consideration of ESOP Scheme
The board will also consider and potentially approve the adoption of the Aster DM Healthcare Limited Employee Stock Option Scheme – 2025 (“ESOS 2025”). This scheme is subject to the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, as well as other relevant legislation and shareholder approval.
Source: BSE
